# Alternative Disruptors: Life Science Real Estate in Transition

Page: https://stenobird.com/podcast/cpe-podcasts-1997541/alternative-disruptors-life-science-real-estate-in-transition
Text version: https://stenobird.com/podcast/cpe-podcasts-1997541/alternative-disruptors-life-science-real-estate-in-transition.md
Podcast: [CPE Podcasts](https://stenobird.com/podcast/cpe-podcasts-1997541)
Published: 2026-05-19T08:34:14+00:00
Episode link: https://podcasters.spotify.com/pod/show/cpexecutive/episodes/Alternative-Disruptors-Life-Science-Real-Estate-in-Transition-e3jj3j3
Audio file: https://anchor.fm/s/9151388/podcast/play/120212515/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-19%2F424450089-44100-2-9416b3088908b.m4a
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/cpe-podcasts-1997541/episodes/alternative-disruptors-life-science-real-estate-in-transition
Duration seconds: 2240

## Resource

Life science real estate has been widely regarded as one of the most resilient sectors of the property market in the U.S. After a surge in new construction that started during the COVID-19 pandemic, the sector is now faced with sharp-rising vacancies in some of the biggest clusters.Long-term drivers like talent, funding, onshoring and biomanufacturing still point to major opportunities, however. In the latest episode of Alternative Disruptors, host Tudor Scolca-Seușan talks with Colliers Executive Vice President Joe Fetterman about where this asset class is headed in 2026 and beyond.Fetterman discusses how the sector evolved in recent years, from the robust enthusiasm felt by investors in 2019 and 2020, to the interest rate increase period and the slow absorption levels in 2024 and 2025.There is hope for the future, however. Fetterman explains why the life science sector’s story is not black and white: while demand for R&D lab space has softened, biomanufacturing is gaining momentum due to onshoring efforts, the U.S. pharma consumption market and blockbuster drug capacity needs.The conversation also covers how investors find opportunities amid oversupply and potential distress, including the case of ‘reversions’ from lab to innovation use or office. Fetterman also touches on the rise of AI and its potential to disrupt the sector.In this episode, you’ll also hear about why the top clusters (Boston, San Diego and San Francisco) are bound to recover faster, as well as which emerging markets have the most potential to become a major hub and why.Here’s a breakdown of the discussion:* (00:00) Intro* (01:08) post-COVID reality check* (04:49) Labs vs. manufacturing split* (08:09) Where opportunity is now* (12:59) Demand drivers and capital* (18:53) Manufacturing durability…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/cpe-podcasts-1997541/episodes/alternative-disruptors-life-science-real-estate-in-transition/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/cpe-podcasts-1997541/alternative-disruptors-life-science-real-estate-in-transition.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.